Literature DB >> 4025575

Hemodynamics during pregnancy and sex steroid administration in guinea pigs.

M V Hart, J D Hosenpud, A R Hohimer, M J Morton.   

Abstract

We investigated the time course and possible mechanisms by which the maternal cardiovascular system adapts to the demands of pregnancy. Control, 20-, 40-, and 60-day gestation guinea pigs (total 68 days) and nonpregnant virgin female guinea pigs chronically dosed with cholesterol (control), estrogen (17beta-estradiol), progesterone, and estrogen plus progesterone were studied. In vivo heart rates, pressures, cardiac outputs, blood volumes, and in vitro left ventricular pressure-volume relations were measured. There was no difference in heart rate, mean arterial, right atrial, or left ventricular end-diastolic pressures, or left ventricular weights between the various pregnant animals or hormone-dosed animals and their respective controls. By 20 days gestation blood volume (24%, P less than 0.005), cardiac output (22%, P less than 0.005), and stroke volume (22%, P less than 0.05) were increased, whereas uterine blood flow was unchanged. Chronic estrogen administration resulted in similar increases in cardiac output (24%, P less than 0.05), stroke volume (31%, P less than 0.05), and blood volume (13%, P less than 0.05). In vitro left ventricular pressure-volume relations were shifted to the right in all pregnant and hormone-dosed groups. Increases in left ventricular size and output occur before changes in uterine blood flow in guinea pig pregnancy, and these adaptations can be elicited by chronic sex steroid administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025575     DOI: 10.1152/ajpregu.1985.249.2.R179

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  [Pregnancy and kidney diseases].

Authors:  M Siekierka-Harreis; L C Rump
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

Review 2.  Sex differences in myocardial metabolism and cardiac function: an emerging concept.

Authors:  Carin Wittnich; Luke Tan; Jack Wallen; Michael Belanger
Journal:  Pflugers Arch       Date:  2013-02-13       Impact factor: 3.657

Review 3.  Pregnancy as a cardiac stress model.

Authors:  Eunhee Chung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

Review 4.  Aerobic exercise during pregnancy. Special considerations.

Authors:  S P Sady; M W Carpenter
Journal:  Sports Med       Date:  1989-06       Impact factor: 11.136

Review 5.  Uteroplacental circulation and fetal vascular function and development.

Authors:  Kent L Thornburg; Samantha Louey
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

Review 6.  Maternal uterine vascular remodeling during pregnancy.

Authors:  George Osol; Maurizio Mandala
Journal:  Physiology (Bethesda)       Date:  2009-02

7.  Cardiac remodelling during pregnancy: whither the guinea pig?

Authors:  Michael J Taggart; Richard Hume; Jon Lartey; Mark Johnson; Wing-Chiu Tong; Kenneth T Macleod
Journal:  Cardiovasc Res       Date:  2014-08-25       Impact factor: 10.787

8.  Assessment of the Cardiac Functions Using Full Conventional Echocardiography with Tissue Doppler Imaging before and after Xylazine Sedation in Male Shiba Goats.

Authors:  Ahmed S Mandour; Haney Samir; Tomohiko Yoshida; Katsuhiro Matsuura; Hend A Abdelmageed; Mohamed Elbadawy; Salim Al-Rejaie; Hussein M El-Husseiny; Ahmed Elfadadny; Danfu Ma; Ken Takahashi; Gen Watanabe; Ryou Tanaka
Journal:  Animals (Basel)       Date:  2020-12-07       Impact factor: 2.752

9.  Change of diurnal heart rate patterns during pregnancy and lactation in dogs (Canis familiaris).

Authors:  K Olsson; A S Lagerstedt; A Bergström; J Häggström
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

10.  Haematological changes in rabbits (Oryctolagus cuniculus f. domesticus) in the course of pregnancy.

Authors:  Maria Chmurska-Gąsowska; Bartosz Bojarski; Leszek Szała
Journal:  Anim Reprod       Date:  2021-07-12       Impact factor: 1.807

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.